CONTACT
NAVARRA
+34 948 194 700
NAVARRA
×
INTRANET
PEOPLE FINDER
English
Español
WORK WITH US
INVESTOR AREA
/servlet/autocompletar/
Delete
DO YOU WANT TO HELP US?
ÚNETE A NUESTRO EQUIPO
ÁREA DE INVERSIÓN
About us
Universidad de Navarra Biomedical Campus
Research Center of the Clínica
Organization
Transparency Portal
Corporate Responsibility (Compliance)
Research
Diseases
Research divisions
Research groups
Technological platforms
Research and clinical trials
Research Staff
Human Resources Strategy for Researchers (HRS4R)
Scientific activity
Innovation
Pipeline
Patents
Entrepreneurship | Spin off
Collaboration with companies
Investor Area
Training
Cima Impulse
Training offer
Training contracts and grants
Collaborate with us
How to collaborate
Collaboration projects
Collaborating companies
Transparency
News
News
Events
Scientific Report 2022-23
Salud y Ciencia
Home
>
News
>
News
Cima Universidad de Navarra news
Specialties
Choose by department
Adhesion and Metastasis
Adoptive Cell Therapy
Adoptive Cellular Therapy
Advanced Therapies for Pediatric Solid Tumors
Advanced Therapies for Rare Liver Diseases
Animal Models
Animal Production and Experimentation
Applied and Translational Onco-Immunology
Aptámeros y Química Médica
Aptamers
Atherothrombosis
Biobank
Biochemical Analysis and Cell Metabolism
Bioinformatics
Biomedical Engineering
Cancer Division
Cancer gene therapy
Cardiac Tissue Engineering
Cardiovascular Diseases
Combination Strategies for Translational Immunotherapy
Computational Biology and Translational Genomics
Cytokine-Based Therapeutics
Cytometry
DNA and RNA Medicine
Dynamics of the antitumor immune response
Enable Technologies
Epigenetics
Epilepsy
Gene Therapy for Hereditary Hearing Loss and AAV Engineering
Gene Therapy for Monogenic Encephalopathies
Gene Therapy for Rare Diseases
Gene Therapy in Neurological Diseases
Gene Therapy in Neurological Disorders
Gene Therapy in Parkinson's Disease
Gene Therapy of Renal Diseases and Study of N-terminal Acetylation of Proteins
Genomics Unit
Heart Failure
Hemato-Oncology
Hepatology
Hepatology: Carcinogenesis and Liquid Biopsy
Hepatology: Metabolism, Epigenetics and Carcinogenesis
Hepatology: Molecular Mechanisms and Targets in liver carcinogenesis
Hepatology: Porphyrias and Carcinogenesis
Image
Immune Therapies
Immunology and Immunotherapy
Immunomodulation and Tumor Microenvironment
In vivo Organ Generation by Stem Cells
Locoregional Immunotherapy Strategies in Peritoneal Carcinomatosis
Lungsearch: Lung cancer Screening, Early detection, biomarkers and new therapeutic targets
Lymphomas
Machine Learning in Biomedicine
Medicinal Chemistry
Micro-PET
Microbiome and Clinical Physiology
Microphysiological Systems and Quantitative Biology
Morphology
Myelodysplastic Neoplasia
Myeloid Pathology
Neuroscience
Next Generation Gene Delivery Technologies
Non-coding RNA and Biotechnology
Noncoding RNA and cancer genome
Oncogenes and Effector Targets
Peptide
Physiological Control and Monitoring
Preclinical Models and Analysis Tools
Predictive Response Marker
Radioactive Facility
Radioimmunotherapy strategies for pediatric tumors
Regulación de la Expresión Génica
Renal Gene Therapy and Chimeric AAV Development
RNA and Senescence
RNA Biology and Therapy
Solid Tumor
Stress Responses and Liver Cancer Immunotherapy
Therapeutic Innovation
Therapeutic Innovation in Lung Cancer
Translational Hematology
Translational Immunomics in Hematological Neoplasms
Translational Oncology
Tumor Evasion and New Targets
Vaccine Development
Date from
Date to
Three new cases of the world's rarest childhood porphyria identified
A consortium of European researchers, led by Cima Universidad de Navarra, describes the first case of ALA dehydratase deficiency porphyria in a female
December 2, 2025
A new cellular atlas reveals the maturation process of human B cells and their involvement in a type of leukemia
Researchers at Cima Universidad de Navarra have defined a multi-omic analysis method that could improve the diagnosis and treatment of diseases such as type B acute lymphoblastic leukemia
November 25, 2025
Spanish oncologists award two-year grant to CCUN doctor to research immunotherapy in kidney cancer
Dr. Iñaki Eguren will develop a project at the Francis Crick Institute in London on the mechanisms of resistance to immunotherapy in advanced kidney cancer
November 21, 2025
FERO awards a grant to a CCUN project to improve immunotherapy in lung cancer patients
Dr. Miguel Fernández de Sanmamed, a specialist at the Cancer Center Clínica Universidad de Navarra, has been awarded a grant for young researchers, which will fund a project on intratumoral immunotherapy in patients with operable lung cancer.
November 19, 2025
November 17, International Lung Cancer Day
“We are here thanks to research”
Lung cancer patients and scientific and healthcare professionals gathered at Cima Universidad de Navarra for a meeting organized in collaboration with the AECC in Navarra
November 14, 2025
El Cima y la Clínica Universidad de Navarra, seleccionados para desarrollar nuevas inmunoterapias contra el cáncer en el proyecto CART_Andalucía
Esta iniciativa estratégica, impulsada por la Junta de Andalucía y gestionada por la Fundación Pública Andaluza Progreso y Salud, busca desarrollar un innovador tratamiento dirigido a pacientes con linfomas y leucemias
November 13, 2025
